U.S. Physical Therapy, Inc. (NYSE:USPH) Shareholders to Get $0.46 Quarterly Dividend

U.S. Physical Therapy, Inc. (NYSE:USPH) declared a quarterly dividend on Tuesday, November 3rd. Shareholders of record on Monday, November 16th will be given a dividend of $0.46 per share on Friday, December 11th. This represents a $1.84 annualized dividend and a yield of 2.1%. The ex-dividend date is Monday, November 16th.

U.S. Physical Therapy has increased its dividend by an average of 0.4% annually over the last three years and has raised its dividend annually for the last 6 consecutive years. U.S. Physical Therapy has a payout ratio of 62.4% meaning its dividend is sufficiently covered by earnings. Equities analysts expect U.S. Physical Therapy to earn $3.42 per share next year, which means the company should continue to be able to cover its $1.84 annual dividend with an expected future payout ratio of 53.8%.

U.S. Physical Therapy Stock Up 5.8%

Shares of NYSE:USPH opened at $89.66 on Thursday. The company has a market capitalization of $1.34 billion, a PE ratio of 527.45, a price-to-earnings-growth ratio of 2.15 and a beta of 1.16. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.27 and a quick ratio of 1.27. The business has a fifty day moving average price of $83.40 and a two-hundred day moving average price of $76.92. U.S. Physical Therapy has a 1 year low of $58.19 and a 1 year high of $90.94.

U.S. Physical Therapy (NYSE:USPH) last announced its earnings results on Wednesday, November 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.76 by $0.04. The firm had revenue of $222.56 million during the quarter, compared to analyst estimates of $214.48 million. U.S. Physical Therapy had a return on equity of 9.39% and a net margin of 3.97%. The business’s revenue was up 12.9% compared to the same quarter last year. During the same period last year, the firm posted $0.66 EPS. Analysts forecast that U.S. Physical Therapy will post 2.89 earnings per share for the current year.

Wall Street Analysts Forecast Growth

USPH has been the subject of several research reports. Citigroup restated a “market outperform” rating on shares of U.S. Physical Therapy in a research report on Wednesday, August 19th. JPMorgan Chase & Co. lifted their price objective on shares of U.S. Physical Therapy from $90.00 to $95.00 and gave the stock an “overweight” rating in a research report on Friday, September 11th. Barrington Research lifted their price objective on shares of U.S. Physical Therapy from $90.00 to $98.00 and gave the stock an “outperform” rating in a research report on Monday, August 10th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of U.S. Physical Therapy in a research note on Wednesday, August 26th. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $98.25.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc (NYSE: USPH) operates outpatient physical therapy clinics throughout the United States. The company provides treatment and rehabilitation services for patients recovering from injuries, surgeries, illnesses and other conditions that affect movement, strength and physical function.

In addition to company-operated clinics, U.S. Physical Therapy develops and manages physical therapy practices in partnership with local physical therapists. Its services generally include orthopedic and sports rehabilitation, post-operative therapy, treatment for musculoskeletal conditions and other forms of outpatient rehabilitation.